tiprankstipranks
Puma Biotechnology (PBYI)
NASDAQ:PBYI

Puma Biotechnology (PBYI) Financial Statements

581 Followers

Puma Biotechnology Financial Overview

Puma Biotechnology's market cap is currently ―. The company's EPS TTM is $0.321; its P/E ratio is 9.64; Puma Biotechnology is scheduled to report earnings on August 1, 2024, and the estimated EPS forecast is $-0.05. See an overview of income statement, balance sheet, and cash flow financials.
Mar 24Dec 23Sep 23Jun 23Mar 23
Income Statement-
Total Revenue$ 43.77M$ 72.18M$ 56.12M$ 54.57M$ 46.79M
Gross Profit$ 33.04M$ 47.85M$ 42.83M$ 42.71M$ 65.99M
EBIT$ -1.24M$ 16.16M$ 9.35M$ 5.64M$ 4.86M
EBITDA$ 1.66M$ 19.05M-$ 0.00$ 7.74M
Net Income Common Stockholders$ -4.82M$ 12.27M$ 5.80M$ 2.13M$ 98.22M
Balance Sheet-
Cash, Cash Equivalents and Short-Term Investments$ 107.16M$ 95.94M$ 85.03M$ 74.44M$ 71.22M
Total Assets$ 214.15M$ 230.53M$ 203.60M$ 200.49M$ 195.24M
Total Debt$ 110.73M$ 111.49M$ 112.22M$ 112.94M$ 113.64M
Net Debt$ 3.57M$ 15.55M$ 27.19M$ 38.50M$ 42.42M
Total Liabilities$ 163.17M$ 177.09M$ 164.86M$ 170.09M$ 169.24M
Stockholders Equity$ 50.98M$ 53.44M$ 38.74M$ 30.40M$ 25.85M
Cash Flow-
Free Cash Flow$ 11.25M$ 10.41M--$ -9.86M
Operating Cash Flow$ 11.25M$ 10.46M$ 10.62M-$ 2.64M
Investing Cash Flow$ -19.08M$ -8.17M$ 11.18M-$ -17.45M
Financing Cash Flow-----
Currency in USD

Puma Biotechnology Earnings and Revenue History

Puma Biotechnology Debt to Assets

Puma Biotechnology Cash Flow

Puma Biotechnology Forecast EPS vs Actual EPS

What's Included in PREMIUM?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis